Business & Finance Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
By
· June 29, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Related
Share on X
Share on Facebook
Share on LinkedIn
Copy Link
Bending Spoons SpA, which acquires struggling software businesses, and some of its backers raised $1.68 billion in a US initial…
By
· July 1, 2026 · 1 min read
US stocks advanced on Tuesday as the main indexes notched their best quarter in six years and traders parsed the…
By
· July 1, 2026 · 1 min read
Jardine Matheson Holdings has hired Christopher Ganis, formerly chief investment officer at sovereign wealth fund Indonesia Investment Authority, as Indonesia…
By
· July 1, 2026 · 1 min read
Leave a Reply